NCT06522984 Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid
| NCT ID | NCT06522984 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Egymedicalpedia |
| Condition | Refractory Melasma |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2025-06-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Melasma is a common acquired disorder of hyperpigmentaion caused by increased melanin production by melanocytes. Melasma is a name derived from the Greek word melas meaning black.It is characterized by the appearance of brownish or grayish symmetrical patches on sun-exposed skin, most commonly on the face. Compared to men, women are more likely to be affected.
Eligibility Criteria
Inclusion Criteria: \- Patients of both sexes with melasma. Exclusion Criteria: * Pregnancy * Lactation * Administration of oral contraceptive pills or any phototoxic drug within 1 month prior to study * Patients with a history of thrombosis, abnormal bleeding profile, known hypersensitivity to TA or HQ, and endocrinal disease.